Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
批准号:
7641103
负责人:
Xinmin Simon Xie
金额:
$28.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-18 至 2012-03-30
关键词:
Absence of pain sensationAdaptive BehaviorsAffectAgonistAnimalsAnti-Anxiety AgentsAnxietyArousalAttentionAttenuatedBehaviorBiological ProcessBoxingBrainComplexConflict (Psychology)CouplingEatingElectronsEquilibriumExhibitsFiberFoodFrightHypothalamic structureImageImmunohistochemistryIn Situ HybridizationInvestigationIon ChannelKnockout MiceLabelLateralLeadLinkMJD1 proteinMediatingMicroinjectionsModelingMotor ActivityMusNaloxoneNerve DegenerationNeuraxisNeuronsNeuropeptidesNociceptionOpiatesOpioid PeptidePainPathway interactionsPeptidesPeripheralPhysiologicalPlayProcessResearchResearch Project GrantsRoleSecond Messenger SystemsSiteSliceSourceSpecificityStressSystemTechniquesTestingWakefulnessalertnessbasebiological adaptation to stressconditioned feardefense responsedepresseddrinkingenhanced green fluorescent proteinfollow-uphypocretininsightmelanin-concentrating hormonenerve supplyneurobehaviornociceptinnon-opioid analgesicorexin Apatch clamppostsynapticprepro-orexinpresynapticpreventreceptorresponserestraintrestraint stresssecond messengertransmission processvigilance
中文摘要
描述(由申请人提供):孤啡肽/孤啡肽FQ(N/OFQ)通过其受体NOP调节伤害感受、应激和焦虑。N/OFQ被认为是一种抗阿片肽,因为中枢N/OFQ引起前伤害感受和应激诱导镇痛(SIA)的逆转。然而,N/OFQ可以影响非阿片类药物介导的镇痛作用,其抗焦虑作用不太可能通过与阿片系统的相互作用来介导。N/OFQ和NOP都在下丘脑中丰富,下丘脑选择性地合成下丘脑泌素/食欲素(Hcrts)。Hcrts调节觉醒和警觉,调节伤害性处理,并有助于SIA。由于N/OFQ和Hcrts产生相反的调制大多数行为和细胞的行动评估,我们假设,N/OFQ发挥其对神经行为的影响,主要是SIA和恐惧或压力诱导的焦虑样行为,通过直接调制Hcrt神经元的活动在外侧下丘脑(LH)和/或相互作用的预计网站,接收N/OFQ和Hcrt输入和共表达其同源受体。我们的初步研究表明,含N/OFQ的纤维接触Hcrt神经元和N/OFQ抑制Hcrt神经元的活动,通过突触前和突触后机制。N/OFQ还抑制食欲素/cameleon 2.1小鼠下丘脑切片中大多数Hcrt神经元的胞质Ca 2+。我们发现,食欲素/共济失调蛋白-3神经退行性(食欲素/共济失调蛋白-3)小鼠在束缚模型中没有表现出SIA。相反,脑室内(icv)给予Hcrt模拟食欲素/共济失调蛋白-3小鼠动物中的SIA,但防止野生型(WT)小鼠中的SIA。此外,外源性Hcrt恢复SIA的动物与中央管理的N/OFQ。这些初步结果支持了我们的假设,并使我们提出了以下具体目标:1。测试含N/OFQ的纤维接触Hcrt神经元的假设,并通过使用标准解剖技术(例如,免疫组织化学、原位杂交和逆行追踪)。我们将使用多重标记定量电子显微镜(EM)技术,以进一步确定是否N/OFQ含有纤维突触接触Hcrt神经元。2.通过使用来自orexin/EGFP小鼠的Hcrt神经元的膜片钳记录和通过使用orexin/cameleon 2.1小鼠的Ca 2+成像来表征N/OFQ对Hcrt神经元的细胞生理调节。3.通过研究N/OFQ对WT和食欲素/共济失调蛋白-3小鼠伤害性感受加工的影响,检验N/OFQ部分通过调节Hcrt系统阻断SIA的假设。4.使用条件性和非条件性恐惧范例,在小鼠中检验N/OFQ部分地通过抑制Hcrt介导的应激和焦虑反应而发挥抗焦虑样作用的假设。这项研究将揭示是否存在一个连接N/OFQ和Hcrt系统的集成神经元回路,该神经元回路提供双重调节以平衡应激反应,特别是与伤害性处理和应激适应相关的应激反应。
英文摘要
DESCRIPTION (provided by applicant): Nociceptin/orphanin FQ (N/OFQ), via its receptor NOP, modulates nociception, stress, and anxiety. N/OFQ is regarded as an anti-opiate peptide because central N/OFQ causes pronociception and reversal of stress- induced analgesia (SIA). However, N/OFQ can affect nonopioid-mediated analgesia, and its anxiolytic effect is unlikely to be mediated through interaction with the opiate system. Both N/OFQ and NOP are abundant in the hypothalamus, where hypocretins/orexins (Hcrts) are selectively synthesized. The Hcrts regulate wakefulness and alertness, modulate nociceptive processing, and contribute to SIA. Because N/OFQ and Hcrts produce opposite modulations for most behaviors and cellular actions assessed, we hypothesize that N/OFQ exerts its effects on neurobehavior, primarily SIA and fear or stress-induced anxiety-like behavior, through direct modulation of Hcrt neuronal activity in the lateral hypothalamus (LH) and/or interaction at the projected sites that receive both N/OFQ and Hcrt inputs and co-express their cognate receptors. Our preliminary studies show that N/OFQ-containing fibers contact Hcrt neurons and that N/OFQ inhibits Hcrt neuronal activity via both pre- and postsynaptic mechanisms. N/OFQ also depresses cytoplasmic Ca2+ in a majority of the Hcrt neurons in orexin/cameleon 2.1 mouse hypothalamic slices. We found that orexin/ataxin-3 neurodegenerative (orexin/ataxin-3) mice exhibit no SIA in the restraint model. Conversely, intracerebroventricular (icv) administration of Hcrt mimicked SIA in orexin/ataxin-3 mice animals but prevented SIA in wildtype (WT) mice. Furthermore, exogenous Hcrt restored SIA in animals treated with centrally administered N/OFQ. These preliminary results support our hypothesis and lead us to propose the following Specific Aims: 1. Test the hypothesis that N/OFQ-containing fibers contact Hcrt neurons and determine the anatomical source(s) of N/OFQ innervation by using standard anatomical techniques (e.g., immunohistochemistry, in situ hybridization, and retrograde tracing). We will use using multiple labeling quantitative electron microscopical (EM) techniques to further determine whether N/OFQ-containing fibers synaptically contact Hcrt neurons. 2. Characterize the cellular physiological modulation of N/OFQ on Hcrt neurons by using patch clamp recordings of Hcrt neurons from orexin/EGFP mice and by Ca2+ imaging using orexin/cameleon 2.1 mice. 3. Test the hypothesis that N/OFQ blocks SIA partly through the modulation of the Hcrt system by investigating N/OFQ effects on nociceptive processing in WT and orexin/ataxin-3 mice. 4. Test the hypothesis that N/OFQ exerts anxiolytic-like effects partly via inhibition of the Hcrt-mediated stress and anxiety responses in mice using both conditioned and unconditioned fear paradigms. The proposed research will reveal whether there is an integrated neuronal circuit linking the N/OFQ and Hcrt systems that provides a dual-modulation to balance stress responses particularly related to nociceptive processing and stress adaptation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
-
批准号:10760089
-
项目类别:
-
资助金额:$149.99万
-
财政年份:2023
-
负责人:Xinmin Simon Xie
-
依托单位:
Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
-
批准号:10786151
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2023
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
-
批准号:10815882
-
项目类别:
-
资助金额:$48.39万
-
财政年份:2023
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of selective Cav3 channel blockers for treatment of neuropathic pain
-
批准号:8779431
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of selective Cav3 channel blockers for treatment of neuropathic pain
-
批准号:9136310
-
项目类别:
-
资助金额:$69.05万
-
财政年份:2014
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of selective Cav3 channel blockers for treatment of neuropathic pain
-
批准号:9143175
-
项目类别:
-
资助金额:$74.17万
-
财政年份:2014
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of patented tricyclic pyrones molecules for the treatment of Alzheimer’s Disease
-
批准号:9442675
-
项目类别:
-
资助金额:$96.07万
-
财政年份:2013
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of patented tricyclic pyrones molecules for the treatment of Alzheimer’s Disease
-
批准号:9744038
-
项目类别:
-
资助金额:$24.09万
-
财政年份:2013
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of Novel Tricyclic Pyrone Drugs for Treatment of Alzheimer Disease
-
批准号:8516617
-
项目类别:
-
资助金额:$29.81万
-
财政年份:2013
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of Novel Tricyclic Pyrone Drugs for Treatment of Alzheimer Disease
-
批准号:8681291
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2013
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of patented tricyclic pyrones molecules for the treatment of Alzheimer’s Disease
-
批准号:9348491
-
项目类别:
-
资助金额:$97.31万
-
财政年份:2013
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of automated neurobehavioral assay for rodent stroke model assessment
-
批准号:8058543
-
项目类别:
-
资助金额:$25.31万
-
财政年份:2011
-
负责人:Xinmin Simon Xie
-
依托单位:
Retrograde Tracers with Suicide Enzyme?Prodrug to Study Specific Neural Circuits
-
批准号:7671675
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2009
-
负责人:Xinmin Simon Xie
-
依托单位:
Treat Neuropathic Pain with Dissolvable Microneedles Containing Anti-CGRP Peptide
-
批准号:8538916
-
项目类别:
-
资助金额:$48.92万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
-
批准号:7877712
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
-
批准号:8112192
-
项目类别:
-
资助金额:$2.18万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Microneedle patches deliver a CGRP antagonist for neurogenic inflammatory pain
-
批准号:7329221
-
项目类别:
-
资助金额:$19.92万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Treat Neuropathic Pain with Dissolvable Microneedles Containing Anti-CGRP Peptide
-
批准号:8454332
-
项目类别:
-
资助金额:$48.99万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
-
批准号:8117803
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Automated Touchscreen-Piezo Monitoring of Mouse Cognition, Activity and Sleep
-
批准号:7272644
-
项目类别:
-
资助金额:$20.02万
-
财政年份:2007
-
负责人:Xinmin Simon Xie
-
依托单位:
海外基金